Members Wealth’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.7M Buy
152,799
+14,814
+11% +$358K 2.03% 11
2026
Q1
$3.34M Sell
137,985
-7,880
-5% -$191K 2% 10
2025
Q4
$3.55M Buy
145,865
+12,807
+10% +$311K 2.22% 10
2025
Q3
$3.23M Buy
+133,058
New +$3.23M 2.05% 12
2025
Q1
$748K Buy
30,946
+139
+0.5% +$3.34K 0.56% 43
2024
Q4
$738K Buy
+30,807
New +$742K 0.55% 41
2024
Q2
$764K Buy
+31,650
New +$748K 0.51% 41

Other funds holding IBDS

Members Wealth's IBDS Position: Q2 2026 in Review

Members Wealth increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 11% in Q2 2026, buying an estimated $358K and bringing the position to 152,799 shares worth $3.7M. The position accounts for 2.03% of the portfolio, ranked #11.

Members Wealth first reported a position in IBDS in Q2 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Members Wealth held 152,799 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $3.7M as of Q2 2026.
  • Members Wealth bought 14,814 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $358K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 2.03% of Members Wealth's portfolio in Q2 2026, its #11 holding.
  • Members Wealth first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Members Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.